4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-039331
President and CEO sold 21,000 shares at $16.00 ($336,000)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2025-10-24 | Option exercise 10b5-1 | +15,000 | $5.40 | $81,000 | 2,040,850 | D |
| Grossman Adam S President and CEO | 2025-10-24 | Sale 10b5-1 | −15,000 | $16.00 | $240,000 | 2,025,850 | D |
| Grossman Adam S President and CEO | 2025-10-24 | Sale 10b5-1 | −6,000 | $16.00 | $96,000 | 2,019,850 | D |
| Derivatives | |||||||
| Grossman Adam S President and CEO | 2025-10-24 | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 750,950 | D | ||
| Open-market sales · 21,000 sh · avg $16.00 · $336,000 | |||||||
Loading xslF345X05/form4.xml…